Report
Nicolas Thorez

Generix Group : Solid FY 2019-20 results. Strong improvement in profitability before a temporary and forced pause due to the health crisis in FY 2020-21

>FY 2019-20 EBITDA better than expected at € 13.5m, i.e. a margin of 17% (+6 points) - Yesterday evening, Generix Group reported results for FY 2019-20 (FY ends 31 March) that were broadly better than we expected. On sales of € 81.1m (already published), showing organic growth of 6% y-o-y, EBITDA came to € 13.5m (vs ODDO BHF € 12.4m), i.e. an improvement in the margin of 6 points to 17%. Adjusted for the impact of IFRS 16 (+€ 2.1m; +3 points), the EBITDA margin came ...
Underlying
Generix Group SA

Generix is engaged in the design and distribution of computer software. Co.'s software programs cover commercial management, accounting, production and the management of human resources.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Nicolas Thorez

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch